The Biochemical Markers Associated with the Occurrence of Coronary Spasm

Area of Science:

• Cardiology
• Biomarker Discovery

Background:

• Coronary artery spasm (CAS) is a significant cause of angina pectoris.
• Current diagnostic methods for CAS, such as provocative testing, are often invasive, risky, and not universally accepted.
• A definitive, widely accepted biomarker for CAS diagnosis and prediction is currently lacking.

Purpose of the Study:

• To explore potential biomarkers associated with the occurrence of coronary artery spasm.
• To evaluate the utility of certain biomarkers in diagnosing CAS, particularly in cases where provocative testing is not feasible or conclusive.

Main Methods:

• Review of existing literature on biomarkers implicated in CAS.
• Analysis of studies reporting elevated levels of specific molecules in patients with CAS.
• Identification of factors related to inflammation, lipid metabolism, oxidative stress, and vasoconstriction.

Main Results:

• Elevated levels of inflammatory factors (e.g., C-reactive protein), lipoprotein (a), and cystatin-C are associated with CAS.
• Mediators like Rho-kinase, and vasoconstrictors serotonin and endothelin-1 are found to be elevated in CAS patients.
• Biomarkers reflecting oxidative status, such as thioredoxin and nitrotyrosine, are elevated post-CAS occurrence.

Conclusions:

• Several biomarkers, including inflammatory factors, lipoprotein (a), cystatin-C, Rho-kinase, serotonin, endothelin-1, thioredoxin, and nitrotyrosine, show potential in the diagnosis and understanding of CAS.
• Blood tests for these biomarkers could serve as a valuable diagnostic aid for CAS, especially when provocative tests are inconclusive or unavailable.